BVF INC/IL Diversified Active

Location: San Francisco, CA

CIK: 0001056807 · Show all filings

Period: Q4 2016 (← Previous) (Next →)

Filing Date: Feb 14, 2017

Total Value: $498M (99.4% shares, 0.6% debt)

Holdings (29)

— BLUEPRINT MEDICINES CORP 18.3%

Value $91.31M Shares 3,255,280 Est. Cost — Unrealized —

CYTK CYTOKINETICS INC 11.8%

Value $58.95M Shares 4,851,691 Est. Cost — Unrealized —

— CHEMOCENTRYX INC 11.6%

Value $57.71M Shares 7,798,572 Est. Cost — Unrealized —

— ARRAY BIOPHARMA INC 8.8%

Value $43.83M Shares 4,986,186 Est. Cost — Unrealized —

— CONCERT PHARMACEUTICALS INC 5.4%

Value $26.92M Shares 2,616,249 Est. Cost — Unrealized —

XENE XENON PHARMACEUTICALS INC 4.7%

Value $23.44M Shares 3,043,805 Est. Cost — Unrealized —

— FORWARD PHARMA A/S 4.2%

Value $20.83M Shares 1,387,853 Est. Cost — Unrealized —

— CTI BIOPHARMA CORP 3.6%

Value $18.05M Shares 44,796,940 Est. Cost — Unrealized —

— COLUCID PHARMACEUTICALS INC 3.5%

Value $17.63M Shares 484,335 Est. Cost — Unrealized —

— GLYCOMIMETICS INC 3.5%

Value $17.24M Shares 2,826,282 Est. Cost — Unrealized —

— ONCOMED PHARMACEUTICALS INC 2.7%

Value $13.57M Shares 1,760,489 Est. Cost — Unrealized —

— CASCADIAN THERAPEUTICS INC 2.7%

Value $13.5M Shares 3,133,224 Est. Cost — Unrealized —

INFIQ INFINITY PHARMACEUTICALS INC 2.1%

Value $10.61M Shares 7,860,808 Est. Cost — Unrealized —

— ACHILLION PHARMACEUTICALS INC COM 2.0%

Value $10.01M Shares 2,423,300 Est. Cost — Unrealized —

FATE FATE THERAPEUTICS INC 1.9%

Value $9.436M Shares 3,759,398 Est. Cost — Unrealized —

— ARQULE INC 1.9%

Value $9.324M Shares 7,400,128 Est. Cost — Unrealized —

ESPR ESPERION THERAPEUTICS INC NE 1.8%

Value $8.924M Shares 712,770 Est. Cost — Unrealized —

— ADURO BIOTECH INC 1.7%

Value $8.503M Shares 745,886 Est. Cost — Unrealized —

— IMMUNE DESIGN CORP 1.5%

Value $7.261M Shares 1,320,164 Est. Cost — Unrealized —

CTMX CYTOMX THERAPEUTICS INC 1.2%

Value $6.097M Shares 554,806 Est. Cost — Unrealized —

— GTX INC DEL 1.2%

Value $5.853M Shares 1,108,433 Est. Cost — Unrealized —

— SUNESIS PHARMACEUTICALS INC 1.0%

Value $5.042M Shares 1,392,720 Est. Cost — Unrealized —

— NIVALIS THERAPEUTICS INC 0.8%

Value $4.176M Shares 1,864,474 Est. Cost — Unrealized —

— OREXIGEN THERAPEUTICS INC 0.6%

Value $3M Shares 10,000,000 Est. Cost — Unrealized —

— PIERIS PHARMACEUTICALS INC 0.5%

Value $2.606M Shares 1,854,768 Est. Cost — Unrealized —

— PAIN THERAPEUTICS INC 0.3%

Value $1.299M Shares 2,278,552 Est. Cost — Unrealized —

— OREXIGEN THERAPEUTICS INC 0.3%

Value $1.279M Shares 734,976 Est. Cost — Unrealized —

XOMA XOMA CORP DEL 0.3%

Value $1.278M Shares 302,800 Est. Cost — Unrealized —

— ANTHERA PHARMACEUTICALS INC 0.0%

Value $40,000 Shares 62,292 Est. Cost — Unrealized —

Ticker	Issuer	Shares	Value	%	Est. Cost	Unrealized	Class	CUSIP
—	BLUEPRINT MEDICINES CORP	3,255,280	$91.31M	18.3%	—	—	COM	09627Y109
CYTK	CYTOKINETICS INC	4,851,691	$58.95M	11.8%	—	—	COM NEW	23282W605
—	CHEMOCENTRYX INC	7,798,572	$57.71M	11.6%	—	—	COM	16383L106
—	ARRAY BIOPHARMA INC	4,986,186	$43.83M	8.8%	—	—	COM	04269X105
—	CONCERT PHARMACEUTICALS INC	2,616,249	$26.92M	5.4%	—	—	COM	206022105
XENE	XENON PHARMACEUTICALS INC	3,043,805	$23.44M	4.7%	—	—	COM	98420N105
—	FORWARD PHARMA A/S	1,387,853	$20.83M	4.2%	—	—	SPONSORED ADR	34986J105
—	CTI BIOPHARMA CORP	44,796,940	$18.05M	3.6%	—	—	COM	12648L106
—	COLUCID PHARMACEUTICALS INC	484,335	$17.63M	3.5%	—	—	COM	19716T101
—	GLYCOMIMETICS INC	2,826,282	$17.24M	3.5%	—	—	COM	38000Q102
—	ONCOMED PHARMACEUTICALS INC	1,760,489	$13.57M	2.7%	—	—	COM	68234X102
—	CASCADIAN THERAPEUTICS INC	3,133,224	$13.5M	2.7%	—	—	COM NEW	14740B606
INFIQ	INFINITY PHARMACEUTICALS INC	7,860,808	$10.61M	2.1%	—	—	COM	45665G303
—	ACHILLION PHARMACEUTICALS INC COM	2,423,300	$10.01M	2.0%	—	—	COM	00448Q201
FATE	FATE THERAPEUTICS INC	3,759,398	$9.436M	1.9%	—	—	COM	31189P102
—	ARQULE INC	7,400,128	$9.324M	1.9%	—	—	COM	04269E107
ESPR	ESPERION THERAPEUTICS INC NE	712,770	$8.924M	1.8%	—	—	COM	29664W105
—	ADURO BIOTECH INC	745,886	$8.503M	1.7%	—	—	COM	00739L101
—	IMMUNE DESIGN CORP	1,320,164	$7.261M	1.5%	—	—	COM	45252L103
CTMX	CYTOMX THERAPEUTICS INC	554,806	$6.097M	1.2%	—	—	COM	23284F105
—	GTX INC DEL	1,108,433	$5.853M	1.2%	—	—	COM NEW	40052B207
—	SUNESIS PHARMACEUTICALS INC	1,392,720	$5.042M	1.0%	—	—	COM PAR	867328700
—	NIVALIS THERAPEUTICS INC	1,864,474	$4.176M	0.8%	—	—	COM	65481J109
—	OREXIGEN THERAPEUTICS INC	10,000,000	$3M	0.6%	—	—	NOTE 2.750% 20	686164AB0
—	PIERIS PHARMACEUTICALS INC	1,854,768	$2.606M	0.5%	—	—	COM	720795103
—	PAIN THERAPEUTICS INC	2,278,552	$1.299M	0.3%	—	—	COM	69562K100
—	OREXIGEN THERAPEUTICS INC	734,976	$1.279M	0.3%	—	—	COM NEW	686164302
XOMA	XOMA CORP DEL	302,800	$1.278M	0.3%	—	—	COM NEW	98419J206
—	ANTHERA PHARMACEUTICALS INC	62,292	$40,000	0.0%	—	—	COM NEW	03674U201